Bettina Reismüller

发表

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study

M. Zucchetti, J. Gerss, M. Schrappe, 2019, Haematologica.

Outcome of Children and Adolescents With a Second or Third Relapse of Acute Lymphoblastic Leukemia (ALL): A Population-based Analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group

B. Meister, A. Attarbaschi, U. Pötschger, 2013, Journal of pediatric hematology/oncology.

Feasibility and tolerability of bevacizumab in children with primary CNS tumors

I. Slavc, D. Luckner, M. Gruber-Olipitz, 2010, Pediatric blood & cancer.

High hyperdiploid acute lymphoblastic leukemia (ALL)—A 25‐year population‐based survey of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group

M. König, O. Haas, B. Meister, 2017, Pediatric blood & cancer.

Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study

A. Attarbaschi, S. Alexander, A. Uyttebroeck, 2016, American journal of hematology.

Long‐term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria – A population‐based report of the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group

O. Haas, B. Meister, G. Henze, 2009, British journal of haematology.

The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment‐related mortality and not an increased relapse rate – a population‐based analysis of 25 years of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group

O. Haas, B. Meister, A. Attarbaschi, 2013, British journal of haematology.

B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL

E. Clappier, A. Baruchel, A. Attarbaschi, 2019, Front. Oncol..

Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.

M. Schrappe, A. Attarbaschi, A. Möricke, 2016, European journal of medical genetics.